USPTO trademark

DIATRANZ

AllowedUSPTOWord markClass 5Class 40Class 42Class 44

"DIATRANZ" is a word mark owned by Otsuka Pharmaceutical Factory, Inc., filed at the USPTO on February 18, 2026. It has been allowed and covers classes 5, 40, 42 and 44.

View Otsuka Pharmaceutical Factory, Inc. portfolioGet this data via the API
Official USPTO record
DIATRANZ trademark as filed
As filed with the USPTO
Status
Allowed
Since September 8, 2026
Filed
February 18, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99659126
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns DIATRANZ

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Otsuka Pharmaceutical Factory, Inc.

Tokushima, Japan

117 trademarks in the portfolioView company

Representative

Kazuyo Morita

Holland & Hart LLP

Goods and services

What the mark covers

The products and services DIATRANZ is filed for, grouped by Nice class.

  • Cells for medical or clinical use; Living cells for medical use; Biologics in the nature of cells for medical use; Biological tissue cultures for medical use; Pharmaceutical preparations for the treatment of diabetes 1; Pharmaceutical preparations in the form of animal cells for the treatment of diabetes 1; Organotherapeutics

  • Custom manufacturing of pharmaceuticals; Providing technical information in the field of pharmaceutical manufacturing

  • Medical research services; Technology advisory services related to medical research; Technology consultation and research in the field of medicines; Providing medical and scientific research information

  • Medical services; Pig breeding services; Medical services, namely, preparing cells for implanting into a human or other animal body; Medical services, namely, encapsulating cells for implanting into humans and other animals; Medical and pharmaceutical consultation

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Assigned to examiner
  7. New application office supplied data entered
  8. Application filing receipt mailed
  9. New application entered
FAQ

About DIATRANZ

Who owns the trademark "DIATRANZ"?

The USPTO trademark "DIATRANZ" (application 99659126) is owned by Otsuka Pharmaceutical Factory, Inc.

What is the status of "DIATRANZ"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DIATRANZ and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2ba9-0312-72a8-9d31-506888042338
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ba9-0312-72a8-9d31-506888042338",
  "object": "trademark",
  "mark_text": "DIATRANZ",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99659126",
  "filing_date": "2026-02-18",
  "nice_classes": [
    5,
    40,
    42,
    44
  ],
  "owners": [
    {
      "name": "Otsuka Pharmaceutical Factory, Inc.",
      "entity_id": "ent_019eb7a7-f011-74d8-ae2b-f22668fbecd0"
    }
  ]
}